Fikret Rifatbegovic
Overview
Explore the profile of Fikret Rifatbegovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
267
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Taschner-Mandl S, Schwarz M, Blaha J, Kauer M, Kromp F, Frank N, et al.
Oncotarget
. 2015 Dec;
7(3):3571-86.
PMID: 26657295
Poor prognosis and frequent relapses are major challenges for patients with high-risk neuroblastoma (NB), especially when tumors show MYCN amplification. High-dose chemotherapy triggers apoptosis, necrosis and senescence, a cellular stress...
12.
Rifatbegovic F, Abbasi M, Taschner-Mandl S, Kauer M, Weinhausel A, Handgretinger R, et al.
PLoS One
. 2015 Sep;
10(9):e0137995.
PMID: 26360775
Background: Metastases in the bone marrow (BM) in form of disseminated tumor cells (DTCs) are frequent events at diagnosis and also at relapse in high-risk neuroblastoma patients. The frequently highly...
13.
Abbasi M, Rifatbegovic F, Brunner C, Ladenstein R, Ambros I, Ambros P
Mol Oncol
. 2014 Dec;
9(3):545-54.
PMID: 25467309
Neuroblastoma is the most common extra-cranial solid tumor in childhood. Presence of disseminated tumor cells (DTCs) in the bone marrow (BM) at diagnosis and at relapse is a common event...